Lista de obras - Ewa Kalinka-Warzocha - Dominio Público Uruguay

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

artículo científico publicado en 2019

Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.

artículo científico publicado en 2007

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia

artículo científico

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

artículo científico publicado en 2019

Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.

artículo científico publicado en 2016

Chemotherapy treatment patterns and neutropenia management in gastric cancer

artículo científico publicado en 2014

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

artículo científico publicado en 2017

Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients

scientific article published on 15 August 2014

Cutaneous melanoma – guidelines for diagnostics and therapy in 2016

artículo científico publicado en 2016

Czerniaki skóry — zasady postępowania diagnostyczno-terapeutycznego w 2016 roku

artículo científico publicado en 2016

Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system.

artículo científico publicado en 2002

Does diabetes alter the risk of neoplasms? Real-world data analysis in Poland: incidence rates for selected neoplasms in patients with diabetes

artículo científico publicado en 2016

Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy

scientific article published on 04 December 2019

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis

scientific article published on 28 June 2013

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

artículo científico publicado en 2019

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

artículo científico publicado en 2020

Guidelines for the diagnosis and management of osteoporosis in Poland : Update 2017.

artículo científico publicado en 2017

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2015

Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.

artículo científico publicado en 2007

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

artículo científico publicado en 2018

Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

artículo científico publicado en 2002

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

artículo científico publicado en 2016

Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma

artículo científico publicado en 2007

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study

artículo científico publicado en 2015

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

article

Nivolumab in previously untreated melanoma without BRAF mutation

artículo científico publicado en 2015

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

artículo científico publicado en 2019

Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2017

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

artículo científico publicado en 2014

Population morbidity in elderly lung cancer patients from Poland with specific trends in elderly women

scientific article published on 20 December 2019

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

artículo científico publicado en 2013

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

artículo científico publicado en 2015

Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancer.

artículo científico publicado en 2015

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.

artículo científico publicado en 2015

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research

artículo científico publicado en 2008

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.

artículo científico publicado en 2015

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

scientific article published on 19 December 2013

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

artículo científico publicado en 2014

Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie w Polsce. Aktualizacja 2017.

artículo científico publicado en 2017

[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]

artículo científico publicado en 2005

[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas]

scientific article published on 01 January 2005

Lista de obras de Ewa Kalinka-Warzocha

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.

Chemotherapy treatment patterns and neutropenia management in gastric cancer

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients

Cutaneous melanoma – guidelines for diagnostics and therapy in 2016

Czerniaki skóry — zasady postępowania diagnostyczno-terapeutycznego w 2016 roku

Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system.

Does diabetes alter the risk of neoplasms? Real-world data analysis in Poland: incidence rates for selected neoplasms in patients with diabetes

Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

Guidelines for the diagnosis and management of osteoporosis in Poland : Update 2017.

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

Population morbidity in elderly lung cancer patients from Poland with specific trends in elderly women

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancer.

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie w Polsce. Aktualizacja 2017.

[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]

[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas]